Hemant Surgical Industries Complete Financial Statements
In FYNone, Hemant Surgical Industries (HSIL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 7.1% and ROE of 12.7%. Full financial statements from FY2025 to FY2025 (1 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Check HSIL market capitalization to track the company's total market size over time.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
HSIL Revenue, Net Profit & EBITDA — Year-on-Year Growth
HSIL YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. See HSIL P/B ratio to compare market price against book value per share.
HSIL Income Statement — Revenue, EBITDA & Net Profit
Hemant Surgical Industries revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 7.1%. For live price, earnings ratios and company overview, see HSIL screener.
| Particulars | None | March 2025 |
|---|---|---|
| Revenue | 0 | 112 |
| Expenses | 0 | 98 |
| EBITDA | 0 | 14 |
| Operating Profit Margin % | 0.00% | 8.00% |
| Depreciation | 0 | 1 |
| Interest | 0 | 2 |
| Profit Before Tax | 0 | 11 |
| Tax | 0 | 2 |
| Net Profit | 0 | 8 |
| Earnings Per Share (₹) | 0.00 | 7.70 |
HSIL Balance Sheet — Assets, Liabilities & Shareholders' Equity
HSIL total assets ₹148 Cr, total equity ₹63 Cr, total liabilities ₹ Cr (2025) — ROE 12.7%.
| Particulars | 2025 |
|---|---|
| ASSETS | |
| Total Assets | 148 |
| Current Assets | 89 |
| Fixed Assets | 40 |
| Capital Work in Progress | 12 |
| Investments | 0 |
| Other Assets | 97 |
| LIABILITIES | |
| Total Liabilities | |
| Current Liabilities | 24 |
| Non-Current Liabilities | |
| SHAREHOLDERS' EQUITY | |
| Total Equity | 63 |
| Share Capital | 10 |
| Reserves & Surplus | 53 |
HSIL Cash Flow Statement — Operating, Investing & Financing
Hemant Surgical Industries operating cash flow ₹9 Cr, investing ₹-30 Cr, financing ₹18 Cr, net cash flow ₹-4 Cr (2025).
| Particulars | March 2025 |
|---|---|
| Operating Activities | 9 |
| Investing Activities | -30 |
| Financing Activities | 18 |
| Net Cash Flow | -4 |